All news

Ukraine records over 5,000 new COVID-19 cases in the last 24 hours

This is 54.7% more than the previous day, according to official data

KIEV, February 4. /TASS/. Ukraine’s health care services registered 5,082 new COVID-19 cases in the past 24 hours, 54.7% more than the previous day when the daily case tally reached 3,285, the country's Health Ministry announced on Thursday.

"As many as 5,082 new coronavirus cases were reported in Ukraine as of February 4, 2021. In particular, 258 children and 220 health workers were infected," the Health Ministry stated.

A total of 1,893 people were sent to hospitals in the last 24 hours, while 9,933 patients recovered and 140 died from complications caused by the coronavirus. Most cases were recorded in the Khmelnitsky (429) and Ivano-Frankovsk (354) regions, as well as in Kiev (342). Ukraine’s COVID-19 total case tally has reached 1,232,246, while 1,055,406 people have recovered and 23,229 have died.

Over the past 24 hours, Ukraine conducted more than 42,100 coronavirus tests, including some 17,000 to detect antibodies and more than 25,000 carried out by PCR method. Since the start of the pandemic, almost 6.3 mln tests have been conducted, while one in five confirmed positive results. The testing covered about 15% of the country’s population.

On January 25, Ukraine lifted the strict quarantine measures introduced on January 8. According to the government's decision, a state of emergency, as well as a general quarantine, will remain in place until February 28, 2021. The country has not launched vaccination against COVID-19 yet. Furthermore, it has refused to use Russia’s Sputnik V and is in talks with other vaccine manufacturers.

Late last year, the country's authorities announced that the Chinese company Sinovac Biotech would supply more than 1.9 mln vaccine doses, of which 700,000 will arrive in February. Furthermore, Ukraine will receive 117,000 doses of the Pfizer vaccine in mid-February and 2.2 mln - 3.7 mln doses of the AstraZeneca vaccine by the end of the second quarter of 2021 under the COVAX international initiative led by the World Health Organization.